Focused Ultrasound

Focused Ultrasound

Clinical trials are now in progress to use focused ultrasound technology to treat neurological conditions such as Parkinson’s disease and essential tremor, as well as brain cancer and other cancers. (Focused ultrasound is currently an FDA-approved treatment for uterine fibroids.)

MR-guided focused ultrasound, also referred to as focused ultrasound ablation, is a non-invasive approach to traditional surgery. By combining ultrasound technology and magnetic resonance (MR), doctors can use focused ultrasound technology to target tissue deep in the body without incisions or radiation.

How it works

With focused ultrasound, multiple intersecting beams of sound  are focused on to a single spot of diseased tissue. The heat causes destruction of a targeted area, similar to how beams of light from a magnifying glass can burn a hole in a leaf.

The procedure takes place within an MRI scanner equipped with a high-energy ultrasound transducer—which allows doctors to target the area using the ultrasound with great accuracy. The patient usually goes home the same day. Focused ultrasound uses a non-invasive approach promoting fast recovery times for the patient.


See how it works

Learn more about focused ultrasound and see how it works to treat specific conditions at the links below.

Focused Ultrasound Technology

Essential Tremor

Brain Tumor

Parkinson's Disease

Research at Swedish

Swedish is currently one of four clinical trial sites in the United States testing the safety of this procedure for neurological treatment.

Learn more about Swedish’s clinical trials

Clinical Trials

A Study to Evaluate the Safety and Feasibility of Transcranial MRI-Guided Focused Ultrasound Surgery in the Treatment of Brain Tumors
Principal Investigator: Stephen Monteith, M.D.

A Pivotal Study to Evaluate the Effectiveness and Safety of ExAblate Transcranial MRgFUS Thalamotomy Treatment of Medication Refractory Essential Tremor Subjects
Principal Investigator: Ryder Gwinn, M.D.

A feasibility study to evaluate safety and initial effectiveness of Exablate Transcranial MR Guided Focused Ultrasound for Unilateral Thalamotomy in the treatment of Medication-Refractory Tremor Dominant Idiopathic Parkinson's Disease
Principal Investigtor: Ryder Gwinn, M.D.

 


Stephen Monteith, MD and David Newell, MD

 

Focused Ultrasound In The News


"Focused Ultrasound Used to Treat Tremors"
www.king5.com/story/news/health/body/2014/08/27/swedish-neuroscience-institute-mri-essential-tremor/14713495/

"Patients' Tremors Stopped After New Non-Invasive, Pain-Free Brain Surgery"
http://abcnews.go.com/WNT/video/sound-waves-cures-grandmothers-tremors-15424464

http://issuu.com/theswedishfoundation/docs/impact-2013-summer

http://www.radiologytoday.net/archive/rt1213p28.shtml

http://www.dotmed.com/news/story/22025?p_begin=0
 

More information about focused ultrasound


http://www.fusfoundation.org/

www.insightec.com/MRgFUS-Technology.html

http://www.fusfoundation.org/diseases-and-conditions/brain-disorders/essential-tremor

http://www.fusfoundation.org/diseases-and-conditions/brain-disorders/brain-tumor

http://www.fusfoundation.org/diseases-and-conditions/brain-disorders/parkinsonian-tremor
 

For more information, please call our Focused Ultrasound Research Line at 206-320-3070.


 

Contact Information

Neuroscience Institute Administrative Office
550 17th Avenue
Suite 500
Seattle, WA 98122
Phone: 206-320-2800
Fax: 206-320-2827
8 a.m. - 4:30 p.m.
Map & Directions